A new trading day began on Monday, with Generation Bio Co (NASDAQ: GBIO) stock price down -3.79% from the previous day of trading, before settling in for the closing price of $0.34. GBIO’s price has ranged from $0.30 to $3.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -8.30% over the last five years. Meanwhile, its annual earnings per share averaged 45.62%. With a float of $45.82 million, this company’s outstanding shares have now reached $67.01 million.
The firm has a total of 115 workers. Let’s measure their productivity. In terms of profitability, gross margin is 100.0%, operating margin of -331.33%, and the pretax margin is -292.92%.
Generation Bio Co (GBIO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Generation Bio Co is 31.65%, while institutional ownership is 54.39%. The most recent insider transaction that took place on Jan 10 ’25, was worth 120,759. In this transaction Director of this company bought 125,791 shares at a rate of $0.96, taking the stock ownership to the 214,286 shares. Before that another transaction happened on Jan 13 ’25, when Company’s Director bought 85,000 for $0.97, making the entire transaction worth $82,450. This insider now owns 299,286 shares in total.
Generation Bio Co (GBIO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 45.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.37% during the next five years compared to -8.30% drop over the previous five years of trading.
Generation Bio Co (NASDAQ: GBIO) Trading Performance Indicators
Here are Generation Bio Co’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.08, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.07 in one year’s time.
Technical Analysis of Generation Bio Co (GBIO)
Analysing the last 5-days average volume posted by the [Generation Bio Co, GBIO], we can find that recorded value of 1.37 million was better than the volume posted last year of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 46.18%.
During the past 100 days, Generation Bio Co’s (GBIO) raw stochastic average was set at 6.56%, which indicates a significant decrease from 27.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.75% in the past 14 days, which was higher than the 94.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3828, while its 200-day Moving Average is $1.0378. Now, the first resistance to watch is $0.3410. This is followed by the second major resistance level at $0.3519. The third major resistance level sits at $0.3613. If the price goes on to break the first support level at $0.3207, it is likely to go to the next support level at $0.3113. Should the price break the second support level, the third support level stands at $0.3004.
Generation Bio Co (NASDAQ: GBIO) Key Stats
With a market capitalization of 22.12 million, the company has a total of 67,035K Shares Outstanding. Currently, annual sales are 19,890 K while annual income is -131,670 K. The company’s previous quarter sales were 8,720 K while its latest quarter income was -14,800 K.
